Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karata¿; Süleyman Serdar Koca; Bünyamin K¿sac¿k;

Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease Ana Urruticoechea-Arana; Jesús Sanz; Daniel Ginard; Yago González-Lama; Xavier Juanola; Miriam Almirall; Natalia Borruel; Jordi Gratacós; Estíbaliz Loza;

Association of Anti-Saccharomyces cerevisiae antibodies with clinical phenotype in spondyloarthritis patients Raquel Miriam Ferreira; Sofia Pimenta; Miguel Bernardes; Lúcia Costa;